This patent appears to cover the stem cell antigen AC133, otherwise known as CD133. This antigen is found not only on hematopoietic stem cells, but also on stem cells capable of inducing angiogenesis.
This patent may be useful for people who do not want to licence CD34.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.